B cell differentiation is controlled by a subset of well-characterized transcription factors that act at distinct checkpoints during hematopoiesis. The first cells in the fetal liver or bone marrow (BM) that are primed for the B cell fate are the common lymphoid progenitors (CLPs). The transcriptional regulators PU.1 and Ikaros are essential for the development of CLPs 1,2 . The CLP population is heterogeneous and can be segregated into two compartments on the basis of expression of the cell surface marker Ly6D. Ly6D − CLPs, called 'all-lymphoid progenitors' (ALPs), display potential to develop into the B cell, T cell and natural killer cell lineages, whereas Ly6D + CLPs, also called 'B cell-biased lymphoid progenitors' (BLPs), give rise mainly to the B cell lineage 3, 4 . The E2A transcriptional regulators control the developmental transition from ALP to BLP 3 . Once the E2A proteins are activated, they induce expression of the gene encoding the transcriptional regulator Foxo1 (Foxo1), which in turn activates expression of the gene encoding the transcriptional regulator EBF1 (Ebf1) 5 . EBF1 and Foxo1 then act in a positive intergenic feedback loop to promote the B cell fate. Developmental progression from the pro-B cell stage to the pre-B cell stage is controlled by the precursor of the B cell antigen receptor (pre-BCR). Once the pre-BCR is expressed on the cell surface, it induces the proliferation of large pre-B cells, which in turn differentiate into small resting pre-B cells. Both pro-B cells and large pre-B cells require the transcription factor c-Myc to promote cellular expansion, cell growth and cell survival 6,7 . The transcriptional regulator Ikaros is essential for promotion of the developmental transition from the large pre-B cell stage to the small pre-B cell stage [8] [9] [10] .
The developmental progress of B cells can also be characterized by the status of the rearrangement of immunoglobulin-encoding genes. The locus encoding the immunoglobulin heavy chain (Igh) undergoes recombination of the diversity (D) region and joining (J) region (D H -J H recombination) starting at the BLP stage, whereas rearrangement of the variable (V), D and J regions (V H -D H J H rearrangement) occurs at the pro-B cell stage. Recombination of the locus encoding the immunoglobulin light chain is initiated and completed at the small pre-B cell stage. Recombination of Igh coincides with commitment to the B lineage and is tightly regulated to ensure that D H -J H recombination precedes V H -D H J H recombination and that the entire V H repertoire is represented. The mouse V H repertoire is composed of over 100 V H segments divided across different families that are segregated into proximal and distal V H segments 11 . During developmental progression, distal V H segments are brought into closer spatial proximity to J H segments through locus contraction 12 . Contraction of the Igh locus is controlled by multiple transcription factors, including E2A, YY1 and Pax5 (refs. [13] [14] [15] .
Lineage-specific transcriptional regulators such as E2A, EBF1 and Foxo1 act mainly by binding to distally located enhancer elements that are characterized by DNase I hypersensitivity, active histone marks and non-coding transcription 16 . On the one hand, enhancers displaying the histone marks of histone H3 monomethylated at Lys4 (H3K4me1), histone H3 dimethylated at Lys4 (H3K4me2) and histone H3 acetylated at Lys27 (H3K27ac) are considered active and are bound by the histone acetyltransferase p300 (ref. 17) . On the other hand, enhancers without deposition of H3K27ac are thought to be in a poised state 17 .
6
VOLUME 16 NUMBER 7 JULY 2015 nature immunology
A r t i c l e s
Enhancers activate transcription by looping to their cognate promoter regions. Promoter-enhancer interactions are facilitated by the mediator or cohesin complexes 18 . Super-enhancers, which represent clusters of enhancers, are frequently associated with developmentally regulated genes and are characterized by a high density of binding of mediators and transcription factors 19 . Enhancer elements need to be established, maintained and/or inactivated during the developmental progression of cells. A key step for enhancer establishment is the removal of nucleosomes to allow occupancy by transcription factors across enhancer regions. Prominent among chromatin remodelers that promote depletion of nucleosomes is the BAF complex 20 . The BAF complex consists of at least 14 subunits encoded by 28 genes. The polymorphic composition of the BAF complex underlies its specialized functions in a tissue-specific manner. Depletion of nucleosomes requires the ATPase activity of the BAF complex members Brm or Brg1, encoded by Smarca2 or Smarca4, respectively 20 .
Here we demonstrate that Brg1 acts at multiple developmental stages to orchestrate B cell development. Specifically, we found that at the onset of B cell development, Brg1 provided transcriptional regulators closely associated with a B lineage-specific transcriptional signature access to a large enhancer repertoire. In committed pro-B cells, Brg1 was essential for accessibility to transcription factorbinding sites across the Igh locus and concomitant merging of distal and proximal V H regions. Finally, we found that Brg1 controlled pro-B cell growth and prevented premature pre-B cell differentiation by permitting EBF1, Ikaros and Pax5 access to a distally located Myc super-enhancer. Together these observations show how a lineagespecific chromatin remodeler specifies cell fate, regulates cell growth and enforces developmental checkpoints.
RESULTS

Brg1 specifies the B cell fate
Published studies have indicated an important role for Brg1 in early B cell development [21] [22] [23] [24] . However, it has remained unclear how Brg1 expression acts to orchestrate B cell fate. As a first approach to addressing this question, we depleted the CLP compartment of Brg1 expression through the use of mice with loxP-flanked alleles encoding Brg1 (Smarca4 fl/fl ) deleted by Cre recombinase expressed from the gene encoding the interleukin 7 (IL-7) receptor α-chain (Il7r Cre/+ ) 25, 26 . The use of Il7r Cre/+ leads to efficient recombination of loxP-flanked alleles in the lymphoid compartment with an onset at the CLP stage in the BM 26 . To alleviate potential defects due to heterozygous nature of ll7r Cre/+ , we directly compared Smarca4 fl/fl Il7r Cre/+ mice with their Smarca4 fl/+ Il7r Cre/+ littermates (control mice). Smarca4 fl/fl Il7r Cre/+ mice did not display gross abnormalities, and their BM cellularity was normal (Fig. 1a) . B cell cellularity, however, was more than tenfold lower in Smarca4 fl/fl Il7r Cre/+ mice than in the Smarca4 fl/+ Il7r Cre/+ control mice (Fig. 1b) . In concordance with published results 24 , the cellularity of the pro-B cell, pre-B cell, immature B cell and mature B cell compartments was greatly reduced in BM Fig. 2a ). The abundance of BLPs was further reduced in the absence of Brg1, and developing Smarca4 ∆/∆ B cells were almost completely undetectable ( Supplementary  Fig. 2a,b) . Together these observations indicated that Brg1 was required for establishment of the B cell fate.
Genome-wide occupancy by Brg1 in pro-B cells As a first approach to determining how Brg1 regulates pro-B cell development, we examined the expression of Smarca4 transcripts during hematopoiesis. For this purpose, we isolated RNA from LSK (Lin − Sca-1 + c-Kit + ) cells, LMPPs (lymphoid-primed multipotent progenitors), ALPs, BLPs, pro-B cells, pre-B cells, immature B cells and mature B cells from wildtype mice and analyzed Smarca4 expression. We found that Smarca4 transcripts were absent or their abundance was low in the majority of hematopoietic progenitors but their abundance was elevated in BLPs relative to that in the rest of the hematopoietic progenitor cells (Fig. 2a) . In cells committed to the B cell lineage, Smarca4 expression was highest in pro-B cells but was decreased in pre-B cells (Fig. 2a) .
To assess the spectrum of Brg1-bound sites across the pro-B cell genome, we performed chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) with an antibody to Brg1. We found that Brg1 occupancy was abundant (13,000 bound sites), with the majority of Brg1 binding detected at putative enhancers (Fig. 2b,c) . Intergenic and intronic regions showed enrichment for Brg1-bound sites, and Brg1-bound sites were associated predominantly with genomic regions that displayed deposition of H3K4me1 and H3K4me2 (Fig. 2b,c) . Brg1 also bound to promoter regions, albeit with much lower frequency than the frequency of its binding to putative enhancer elements (Fig. 2b,c) . 
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To evaluate the degree of overlap between Brg1 occupancy and an active enhancer repertoire, including super-enhancers, we compared Brg1-bound sites with those occupied by p300. Notably, a large fraction of Brg1-bound sites overlapped with those occupied by p300 (Fig. 2d) , which indicated that Brg1 associated mainly with an active enhancer repertoire. As expected, we observed Brg1 occupancy across enhancer elements that exhibited binding of E2A and p300 and were associated with the expression of a subset of B lineage-specific genes, including Pax5 and Cd19 (Fig. 2e) . At a genome-wide level, sites occupied by Brg1 showed considerable enrichment for consensus binding motifs for the transcription factors E2A, EBF1, IRF, Ikaros, PU.1 and Runx (Fig. 2f) . Consistent with that analysis, sites occupied by Brg1 were closely associated with those occupied by Ikaros and, to a lesser degree, with E2A-, EBF-, Pax5-and PU.1-bound sites (Fig. 2g) . In contrast, Brg1-bound sites were not frequently associated with sites occupied by the transcriptional repressor CTCF (Fig. 2g) . We observed binding of Brg1 at super-enhancers, including the Foxo1 and Inpp5d superenhancers (Supplementary Fig. 3a) . The proportion of Brg1 bound to super-enhancers was comparable to that of transcription factors known to associate with super-enhancers, such as E2A, Pax5 and Med1 (a member of the mediator complex) (Supplementary Fig. 3b ). To assess the strength with which Brg1 bound to super-enhancers, we normalized the number of tag counts to the size of the enhancers, since the median size of super-enhancers is approximately tenfold greater than that of typical enhancers 19 . We found that unlike results obtained for Med1, the strength of Brg1's binding was not greater at superenhancers than at typical enhancers ( Supplementary Fig. 3c ).
Published studies have established that Ikaros interacts with Brg1 (refs. 27, 28) . Such findings raised the question of whether Ikaros recruits Brg1 to the pro-B cell enhancer repertoire. Hence, we investigated the binding of Ikaros in progenitors of B cells using E2A-deficient pre-pro-B cells 29 . We found that Ikaros bound to a spectrum of sites in pre-pro-B cells distinct from that observed in pro-B cells, even though the expression of Ikaros protein was similar in both cell types 30 ( Supplementary  Fig. 4a) . Notably, the 'de novo' enhancer repertoire associated with pro-B cells ('new' compared with that in pre-pro-B cells) displayed overlapping Fig. 4a ). Furthermore, pro-B cell-specific Brg1-bound sites were associated with regions that underwent depletion of nucleosomes during the transition from the pre-pro-B cell stage to the pro-B cell stage (Supplementary Fig. 4b ). Collectively, these results showed that Brg1 binding was closely associated with a de novo enhancer repertoire that was established during the transition from pre-pro-B cell to pro-B cell.
Brg1 facilitates access to enhancer repertoires As Brg1 is a chromatin remodeler and is required for specification of the B cell fate, we considered the possibility that Brg1 might serve a crucial role in the generation of a de novo enhancer repertoire by facilitating the depletion of nucleosomes across an ensemble of B lineage-specific enhancers. The expression of genes associated with the establishment of B cell identity is activated in BLPs, which suggests that a pro-B cell-specific enhancer repertoire is established in the BLP compartment. As a first approach to exploring this possibility, we used ATAC ('assay for transposase-accessible chromatin') sequencing (ATAC-Seq) to capture open chromatin sites 31 . ATAC-Seq generates results comparable to those obtained by mapping of DNase I-hypersensitivity sites and involves incubation of nuclei with a transposase. The transposase 'preferentially' integrates into active 
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A r t i c l e s regulatory regions and simultaneously fragments and tags the genome with sequencing adaptors. This technique can be used for small numbers of cells, including progenitor populations 31 . To identify accessible enhancer repertoires in progenitors of B cells, we sorted ALPs and BLPs from Smarca4 fl/+ Il7r Cre/+ and Smarca4 fl/fl Il7r Cre/+ mice. We incubated the sorted cells with transposase and sequenced the results at a global scale. Next, we plotted ATAC-Seq tag counts as a function of genomic separation from E2A-, Ikaros-, EBF1-or CTCF-bound sites (Fig. 3a) . As expected, enhancer repertoires associated with occupancy by E2A, Ikaros or EBF1 were more accessible to transposase activity in BLPs than in ALPs (Fig. 3a) . These data indicated that at a developmental stage at which progenitor cells become specified to the B lineage, the enhancer repertoire associated with a B lineage-specific program of gene expression became depleted of nucleosomes. In contrast, Brg1-deficient BLPs displayed either no increase in the number ATAC reads for enhancer repertoires associated with occupancy by E2A, Ikaros or EBF1 relative to that in ALPs or a reduced increase compared with that of Brg1-sufficient BLPs (Fig. 3a) . Genomic regions associated with CTCF occupancy showed comparable ATAC tag counts in both Brg1-sufficient and Brg1-deficient ALPs and BLPs (Fig. 3a) . Since E2A and EBF1 directly regulate Foxo1 expression in the BLP compartment, we investigated whether putative enhancers associated with the Foxo1 locus underwent depletion of nucleosomes 5 . We found that, indeed, Brg1 expression was essential for the eviction of nucleosomes across a distally located Foxo1 enhancer associated with occupancy by E2A and EBF1 (Fig. 3b, left) . Likewise, Brg1 expression was required for the depletion of nucleosomes across a regulatory element located within the Cd79a locus (which encodes the immunoglobulin α-chain) (Fig. 3b, right) .
The increase in accessibility observed in BLPs relative to accessibility in ALPs might have simply reflected increased abundance of the B lineage-specific transcription factors. To exclude this possibility, we examined E2A protein expression in ALPs and BLPs from mice expressing green fluorescent protein (GFP)-tagged E2A (E2A-GFP mice) 32 . We found that abundance of E2A protein did not change during the ALP-to-BLP transition (Fig. 3c) . Likewise, the abundance of transcripts encoding E2A (Tcf3) and Ikaros (Ikzf1) was equivalent in ALPs and BLPs (Fig. 3d) . Thus, the enhancement in open chromatin seen at E2A-binding sites in Brg1-sufficient BLPs relative to its presence in ALPs could not readily be explained in terms of elevated protein expression. Instead, we suggest that Brg1 facilitated the depletion of nucleosomes across an enhancer repertoire closely associated with a B lineage-specific program of gene expression.
Brg1 is essential for promoting Igh locus contraction
Since Brg1 abundance is particularly substantial in pro-B cells and Brg1 binds together with factors that are associated with contraction of the Igh locus, we assessed occupancy of the Igh locus by Brg1. As reported 21 , Brg1 bound to J H segments (Fig. 4a) A r t i c l e s was dispersed throughout the Igh locus and overlapped with the deposition of H3K4me2 and regions depleted of nucleosomes, as revealed by ATAC-Seq (Fig. 4a) . Upon inspecting Hi-C data (meta-analysis of chromosome-conformation capture followed by deep sequencing) generated from pro-B cells, we observed an intricate pattern of significant short-range genomic interactions that spanned the entire cluster of V H segments (Fig. 4a) , consistent with an organization of bundles of loops 33, 34 . Notably, we identified a giant loop connecting the extreme ends of the Igh locus and thus identified the boundaries that define the Igh topological domain (Fig. 4a) . We also identified a spectrum of long-range genomic interactions involving distal V H region clusters and Igh segments across the 3′ end of the locus and found that a subset of these putative anchors showed enrichment for Brg1 occupancy (Fig. 4a,b) . Genomic interactions involving Brg1 showed enrichment mainly for binding of lineage-specific transcription factors, including Pax5, EBF1, YY1, Ikaros and E2A, as well as Med1, relative to the general occupancy of the transcription factor on the Igh locus (Fig. 4c) .
To determine whether Brg1 modulated the accessibility of transcription factor-binding sites across the Igh locus, we assessed ATAC-Seq 'reads' in Brg1-sufficient and Brg1-deficient pro-B cells. We isolated pro-B cells from B220 + cell populations obtained from Smarca4 +/+ ER-Cre and Smarca4 fl/fl ER-Cre BM and expanded these populations in the presence of IL-7 and stem-cell factor. We found that the vast majority of pro-B cells underwent depletion of Brg1 protein upon culture of the cells for 3 d in the presence of tamoxifen (data not shown). As expected, loss of Brg1 expression was closely associated with decreased chromatin accessibility for a large fraction of sites (50%) bound by lineage-specific transcription factors, but not those bound by CTCF (Fig. 4d,e) . The abundance of RNA transcripts encoding lineage-specific transcription factors was not affected by depletion of Brg1 expression (Supplementary Fig. 5a ). Consistent with reduced binding of Pax5 and YY1, we observed a reduction in antisense transcription associated with distal regulatory regions called 'PAIR elements' 35, 36 (Supplementary Fig. 5c ).
Our findings indicated that Brg1 occupancy across the Igh locus was closely associated with transcription factor-binding sites. The transcription factors that bind to these sites have been linked to contraction of the Igh locus [13] [14] [15] . These observations raised the possibility that Brg1 acts to evict nucleosomes positioned across regulatory elements that mediate long-range genomic interactions. To investigate this possibility, we measured the spatial distances separating the distal V H region cluster from a genomic region located 3′ of the Igh locus. Specifically, we obtained pro-B cells from mice deficient in recombination-activating gene 1 (Rag1 −/− mice) to look at germline configuration of the Igh locus and depleted the cells of Brg1 expression through the transduction of short hairpin RNA (shRNA) directed against Smarca4. We then examined the topology of the Igh locus in the transduced pro-B cells by threedimensional fluorescence in situ hybridization. Notably, we found that the Igh locus displayed significant long-range decontraction of the locus in the pro-B cell population upon depletion of Brg1 expression ( Fig. 4f and Supplementary Fig. 5b ). Since reduced contraction should lead to 'preferred' use of the proximal V H segments, we assessed the use of proximal and distal V H segments in pre-B cells sorted from Smarca4 fl/+ Il7r Cre/+ or Smarca4 fl/fl Il7r Cre/+ mice. In agreement with the reduction in contraction of the Igh locus in Rag1 −/− pro-B cells depleted of Brg1, we found significantly more use of proximal V H 7183 segments than distal J H 558 segments in Smarca4 fl/fl Il7r Cre/+ pre-B cells than in Smarca4 fl/+ Il7r Cre/+ pre-B cells (Fig. 4g) . Together these observations indicated that Brg1 was essential for promoting contraction of the Igh locus.
Brg1 regulates Myc expression to promote pro-B cell growth
To determine whether in committed pro-B cells Brg1 acts to maintain an active enhancer repertoire, we isolated RNA from Brg1-sufficient and Brg1-deficient pro-B cells and analyzed the RNA by high-throughput sequencing technologies for cDNA (RNA-Seq). We found that approximately 1,800 genes displayed significant differences in transcript abundance in pro-B cells depleted of Brg1 expression relative to their abundance in Brg1-sufficient pro-B cells (Fig. 5a) . We found that at least 1,000 genes underwent a change in expression of twofold or more upon depletion of Brg1 (Supplementary Table 1) . Notably, gene-ontology analysis showed that the absence of Brg1 affected the expression of a spectrum of genes encoding products associated with ribosome biogenesis (Fig. 5b) . The abundance of transcripts encoding products associated with the metabolism of rRNA and the synthesis of non-coding RNA was also lower in Brg1-deficient (Fig. 5b) . Finally, we found that the abundance of Myc transcripts was significantly lower in Brg1-deficient pro-B cells than in Brg1-sufficient pro-B cells (Fig. 5a) . Real-time PCR analysis confirmed the downregulation of Myc expression in Brg1-deficient pro-B cells and also in Rag1 −/− pro-B cells transduced with shRNA directed against Smarca4 (Fig. 5c) .
The decrease in the abundance of Myc transcripts upon depletion of Brg1 expression raised the question of how Brg1 regulates Myc expression. As a first approach to addressing this question, we inspected the Myc locus for Brg1 occupancy. Brg1 occupancy was particularly prominent in a distally located regulatory element that have been shown to modulate Myc expression in leukemic cells 37 ( Fig. 5d,e) . We found that in pro-B cells, the distally located superenhancer showed deposition of H3K4me2 and was associated with occupancy by Brg1, EBF1, Ikaros and Pax5 (Fig. 5d,e) . Furthermore, Hi-C analysis showed that in pro-B cells, the super-enhancer contacted the Myc promoter with relatively high frequency (Fig. 5d) . To assess whether Brg1 expression was needed to permit B lineagespecific transcription factors access to the Myc super-enhancer, we examined Ikaros occupancy by ChIP in wild-type and Brg1-deficient pro-B cells. Indeed, occupancy by Ikaros at the Myc super-enhancer was much lower in the absence of Brg1 than in the presence of Brg1 (Fig. 5f) . To directly assess whether Brg1 expression was required for the eviction of nucleosomes across the Myc super-enhancer, we analyzed chromatin accessibility in Brg1-sufficient and Brg1-deficient pro-B cells by ATAC-Seq. As expected, we found that Brg1 expression modulated the accessibility of chromatin to the Myc super-enhancer (Fig. 5e) .
c-Myc is known to control cell growth by regulating ribosome biogenesis 38 . To determine whether c-Myc directly regulated the expression of genes encoding products that regulate ribosome biogenesis, we examined c-Myc occupancy in pro-B cells by ChIP-Seq. Notably, in pro-B cells, we observed binding of c-Myc in promoter regions of genes encoding products associated with ribosome biogenesis, including Tsr1 and Gar1 (Fig. 6a) . These findings raised the possibility that in pro-B cells, Brg1 activated Myc expression, which in turn, acted to induce the expression of an ensemble of genes encoding products involved in ribosome biogenesis. We found that the expression of genes associated with the binding of c-Myc in pro-B cells was significantly lower in Brg1-deficient than in Brg1-sufficient pro-B cells (Fig. 6b) .
Globally, approximately 12% of the genes with lower transcript abundance in Brg1-deficient pro-B cells than in Brg1-sufficient pro-B cells were direct targets of c-Myc (Supplementary Table 1) .
To assess directly whether Brg1 acts to regulate pro-B cell growth, we monitored the proliferation of pro-B cells in vivo in Smarca4 fl/+ Il7r Cre/+ and Smarca4 fl/fl Il7r Cre/+ mice through incorporation of the thymidine analog BrdU. Specifically, at 4 h after injection of BrdU, we isolated BM from Smarca4 fl/+ Il7r Cre/+ and Smarca4 fl/fl Il7r Cre/+ mice and analyzed incorporation of BrdU in the pro-B cell compartment. As we expected, BrdU incorporation indicated a significantly lower degree of proliferation in the pro-B cell population isolated from Smarca4 fl/fl Il7r Cre/+ mice than in that from Smarca4 fl/+ Il7r Cre/+ mice (Fig. 6c) . Together these observations indicated that in pro-B cells, Brg1 permitted a subset of B lineage-specific transcription factors access to a super-enhancer to directly activate expression of the gene encoding c-Myc, which in turn induced the expression of genes encoding products associated with ribosome biogenesis, to control the growth of pro-B cells.
Brg1 enforces a pro-B cell-specific transcription signature To examine in greater detail the spectrum of genes affected by the loss of Brg1 expression, we compared the differences in transcript abundance in Brg1-sufficient pro-B cells versus Brg1-deficient pro-B cells to the differences during the CLP-to-pro-B cell transition. The transcription signatures of pro-B cells depleted of Brg1 expression relative to those of wild-type pro-B cells did not correlate with the changes in expression that occurred during the CLP-to-pro-B cell transition (Fig. 7a, left) . However, the transcription profiles of Brg1-deficient pro-B cells versus those of wild-type pro-B cells correlated with changes in transcription signatures that accompanied the pro-B cell-to-pre-B cell transition (Fig. 7a, right) . For example, the abundance of Cd79b transcripts was greater, whereas the abundance of Dntt transcripts was lower, in the absence of Brg1 than in the presence of Brg1 (data not shown). These data suggested that Brg1 acted in pro-B cells to suppress a pre-B lineage-specific pattern of gene expression. To confirm those findings in vivo, we examined Smarca4 fl/+ Il7r Cre/+ and Smarca4 fl/fl Il7r Cre/+ mice for changes in the ratio of pro-B cells to pre-B cells. As predicted, we found that the ratio of small pre-B cells 
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A r t i c l e s to pro-B cells was significantly increased in mice that had undergone depletion of Brg1 expression (Fig. 7b) . Notably, the large pre-B cell compartment was the most severely affected among the B cell compartments from the BM (Supplementary Fig. 6a ), consistent with a requirement for Brg1 in the promotion of cell growth. In further support of that notion, we found that sorted pro-B cells derived from Smarca4 fl/fl ER-Cre mice led to a 'preferential' loss of large cells and an increase in the fraction of small pre-B cells upon culture of the cells with tamoxifen, compared with their abundance among sorted and treated Smarca4 +/+ ER-Cre pro-B cells (Supplementary Fig. 6b,c) .
To determine how these findings mechanistically related to changes in transcription signatures during the pro-B cell-to-pre-B cell transition, we assigned c-Myc-binding sites to the nearest transcription start site and compared c-Myc occupancy with gene-expression patterns in pro-B cells and pre-B cells. Notably, we found that the expression of an ensemble of genes associated with c-Myc-bound sites in pro-B cells was closely associated with a pro-B cell developmental stagespecific program of gene expression and was downregulated at the pre-B developmental stage (Fig. 7c) . Together these data indicated that Brg1 acted to prevent the premature differentiation of pro-B cells into pre-B cells by regulating Myc expression.
DISCUSSION
It is now established that during developmental progression, transcriptional regulators act together to establish de novo enhancer repertoires as cells differentiate along distinct trajectories 39, 40 . The development of early progenitors of B cells is among the best characterized in terms of the transcription factors that modulate the developmental progression. However, it is less clear how lineage-specific transcription factors activate de novo or poised enhancer repertoires to initiate lineage-specific programs of gene expression. Published studies have demonstrated that chromatin remodelers, including the BAF complex, act to promote nucleosome depletion to permit transcription factors access to their cognate binding sites 41, 42 . Here we mapped the spectrum of Brg1-binding sites across the pro-B cell genome. We found that Brg1 occupancy did not overlap with that of one distinct transcription factor but instead overlapped with that of combinations of transcription factors, including E2A, EBF1, Ikaros and members of the IRF family. How, then, is Brg1 recruited to a B lineage-specific enhancer repertoire with different and unique combinations of transcription factor-binding sites? We found that in pro-B cells, occupancy by Brg1 and p300 overlapped across the majority of the pro-B cell enhancer repertoire. p300 is recruited to active enhancer elements by directly interacting with a multitude of transcription factors 43 . Thus, we propose that in the CLP compartment, E2A, Foxo1, Ikaros and EBF1 bind to a repertoire of primed and partially opened enhancers. This binding results in the recruitment of p300, a histone acetylase, to an ensemble of B lineage-specific enhancers. The sequestration of p300 to poised enhancers leads to the deposition of H3K27ac, which recruits Brg1, which in turn evicts and/or slides nucleosomes away from the repertoire of poised enhancers. The role of Brg1 in B cell development is not restricted to specification of the B cell fate. Our data indicated multiple roles for Brg1 in cells committed to the B lineage, including contraction of the Igh locus. During early B cell development, the Igh locus undergoes large-scale alterations that merge the proximal and distal V H regions into a single domain as progenitor cells differentiate into pro-B cells 12 . How does a chromatin remodeler such as Brg1 promote the merging of chromatin domains? We found that Brg1 bound to multiple sites scattered across the entire Igh locus. Published studies have demonstrated that contraction of the Igh locus is regulated by multiple transcription factors, including E2A, Pax5, Ikaros and YY1 (refs. 13-15) . Here we demonstrated that Brg1 expression was essential for the eviction of nucleosomes across regulatory elements of the Igh locus containing clusters of binding sites for Pax5, YY1, E2A and EBF1. We found that a subset of these sites was associated with long-range genomic interactions that connected the distal V H region cluster with more proximally located anchors possibly to promote Igh locus contraction.
Our data also indicated that Brg1 acted in committed pro-B cells to maintain Myc expression and promote cell growth. Brg1 was needed to activate Myc expression by associating with a distally located super-enhancer. The distal super-enhancer of Myc has been identified in acute myelogenous leukemia, in which Brg1 is essential for maintaining Myc expression and promoting the development of leukemia 37, 44 . We found that Brg1 was critical for maintaining accessibility of this super-enhancer and allowing binding of transcription factors. Downregulation of Myc expression caused further downregulation of the expression of genes encoding products associated with the control of lymphocyte growth. Specifically, a wide spectrum of genes encoding products associated with ribosome biogenesis, including factors associated with nucleoli and members of the exosome complex, were downregulated in the absence of Brg1 and exhibited c-Myc binding. Consistent with those findings, we found that the large pre-B cell population was 'preferentially' reduced in Brg1-deficient mice compared with that in Brg1-sufficient mice. Thus, we suggest that Brg1 expression promotes the population expansion of pro-B cells and large pre-B cells by elevating the abundance of c-Myc. The c-Myc in increased abundance, in turn, associates with a repertoire of promoters of genes encoding products associated with cell growth and protein synthesis. During the transition from the pro-B cell stage to the small resting pre-B cell stage, Brg1 levels decrease, as do c-Myc levels. Interestingly, we found that depletion of Brg1 expression in the pro-B cell compartment led to the aberrant activation of genes upregulated at the pre-B cell developmental stage. Since we found that occupancy by c-Myc was associated with genes with higher expression at the pro-B cell stage than at the pre-B cell stage, we suggest that premature exit from the cell cycle through downregulation of c-Myc expression induces a pre-B cell developmental stage-specific program of gene expression, consistent with published observations connecting exit from the cell cycle with developmental progression 45 .
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. GEO: ATAC-Seq data, Brg1 and Ikaros ChIP-Seq data, and RNA-Seq data, GSE66978.
